OrthoAccel said that the AcceleDent is a simple dental device that orthodontic patients wear in the mouth for 20 minutes daily to accelerate tooth movement. It represents the clinical approach to safely accelerate orthodontic tooth movement via modulating biology.

The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. The device works complementary with all existing orthodontic technologies. It is neither FDA cleared nor FDA approved, it is currently investigational in the US.

Houston based OrthoAccel has been granted clearance by the Australian Therapeutic Goods Administration in late 2009. OrthoAccel plans to make AcceleDent available on a limited basis to select Australian orthodontic specialists. It is anticipating the conclusion of another US clinical trial at the UT Health Science Center in San Antonio with a target completion date later in 2010.

Michael Kaufman, VP of business development and marketing at OrthoAccel, said: “The purpose of our visit to Australia was two-fold. We were able to introduce AcceleDent to the Australian market and visit with a number of local orthodontic specialists. At the same time, because of the international attendance, it provided an opportunity to learn more about other global markets that may be of interest in the future as we grow.”